None listed
Conditions
Brief summary
The purpose of the present investigation was to examine the effects of a krill oil supplement on omega-3 index and other fatty acids and whether there are any differences according to age, body weight and gender.
Interventions
Open label interventional trial for which fifty individuals consumed one capsule of Superba™ Boost, containing 1g krill oil (290mg omega-3 providing 160mg of EPA and 80mg of docosahexaenoic acid DHA) orally, each day over 12-weeks and attend study visits at baseline and 6 and 12-weeks. Compliance will be monitored by measurement of omega-3 index at baseline, week 6 and 12 as well as asking participants to keep a study diary documenting when the krill oil supplements are taken.
Sponsors
Western Sydney University
Study design
Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Healthy volunteers
Yes
Inclusion criteria
Aged 18-75 Ability to provide informed consent Baseline omega-3 index less than 8% Not consumed fish oil supplements within three months Not consumed more than four serves of fatty fish per month within the past three months Not taking anticoagulant, antihypertensive or antihyperlipidaemic medications Non-smoker
Exclusion criteria
Omega-3 index was in the high range (i.e. >8%) Consumption of fish oil supplements or fatty fish more than four times a month within the past three months Taking anticoagulant, antihypertensive or antihyperlipidaemic medications Cigarette smokers
Outcome results
None listed